Targeting Bcl-2 Family of Proteins: An Important Strategy in Cancer Therapeutics

Publisher： Bentham Science Publishers

E-ISSN： 1872-3136 |5|1|38-43

ISSN： 2212-7968

Source： Current Chemical Biology, Vol.5, Iss.1, 2011-01, pp. : 38-43

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human 90 kDa Heat Shock Protein Hsp90 as a Target for Cancer Therapeutics

By  

Current Chemical Biology, Vol. 3, Iss. 1, 2009-01 ,pp. : 10-21

Bentham Science Publishers

Access to resources Recommend Favorite

On the Biomaterials for Nanostructured Ocular Therapeutics

By  

Current Organic Chemistry, Vol. 19, Iss. 15, 2015-01 ,pp. : 1443-1459

Bentham Science Publishers

Access to resources Recommend Favorite

The Povarov Reaction as a Versatile Strategy for the Preparation of 1, 2, 3, 4-Tetrahydroquinoline Derivatives: An Overview

By  

Current Organic Synthesis, Vol. 13, Iss. 2, 2016-04 ,pp. : 157-175

Bentham Science Publishers

Access to resources Recommend Favorite

Regulation of G-Protein-Coupled Receptor Signalling by the Scaffolding Proteins Spinophilin/Neurabin 2 and Neurabin 1

By  

Current Chemical Biology, Vol. 5, Iss. 2, 2011-05 ,pp. : 130-141

Bentham Science Publishers

Access to resources Recommend Favorite

GIP-Based Therapeutics for Diabetes and Obesity

By  

Current Chemical Biology, Vol. 2, Iss. 1, 2008-01 ,pp. : 60-67

Bentham Science Publishers

Access to resources Recommend Favorite